Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jun;52(6):444-453.
doi: 10.1055/a-1117-3166. Epub 2020 Mar 2.

Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Affiliations
Free article
Multicenter Study

Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Emmanuel Forté et al. Endoscopy. 2020 Jun.
Free article

Abstract

Background: Gastric hyperplastic polyps (GHPs) have a risk of neoplastic transformation reaching 5 %. Current endoscopic resection techniques appear suboptimal with a high risk of local recurrence. This study assessed the outcomes of endoscopic resection for GHPs and identified risk factors for recurrence and neoplastic transformation.

Methods: This retrospective, multicenter, European study included adult patients with at least one GHP ≥ 10 mm who underwent endoscopic resection and at least one follow-up endoscopy. Patients with recurrent GHPs or hereditary gastric polyposis were excluded. All data were retrieved from the endoscopy, pathology, and hospitalization reports.

Results: From June 2007 to August 2018, 145 GHPs in 108 patients were included. Recurrence after endoscopic resection was 51.0 % (74 /145) in 55 patients. R0 resection or en bloc resection did not impact the risk of polyp recurrence. In multivariate analysis, cirrhosis was the only risk factor for recurrence (odds ratio [OR] 4.82, 95 % confidence interval [CI] 1.33 - 17.46; P = 0.02). Overall, 15 GHPs (10.4 %) showed neoplastic transformation, with size > 25 mm (OR 10.24, 95 %CI 2.71 - 38.69; P < 0.001) and presence of intestinal metaplasia (OR 5.93, 95 %CI 1.56 - 22.47; P = 0.01) being associated with an increased risk of neoplastic transformation in multivariate analysis.

Conclusions: Results confirmed the risk of recurrence and neoplastic transformation of large GHPs. The risk of neoplastic change was significantly increased for lesions > 25 mm, with a risk of high grade dysplasia appearing in polyps ≥ 50 mm. The risk of recurrence was high, particularly in cirrhosis patients, and long-term follow-up is recommended in such patients.

PubMed Disclaimer

Conflict of interest statement

Dr. Pioche has provided training funded by Olympus, Norgine, and Cook. Dr. Vanbiervliet is a consultant for Boston Scientific Corp. and Cook Medical. Dr. Albéniz has participated in practical courses or talks with Olympus, Boston, Norgine, and Casen-Recordati, and has received a grant from “La Caixa/Caja Navarra” Foundation. Dr. Marín-Gabriel has provided training funded by Olympus Iberia, SimMedica, Norgine Iberia, Casen Recordati, and Cook, and has received research funding from Cook. Dr. Giovannini is a consultant for Cook Medical and Pentax Medical. All other authors declare no conflicts of interest.

Comment in

Publication types